Jennifer Straumins Sells 100,000 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Jennifer Straumins sold 100,000 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00. Following the completion of the sale, the director now directly owns 1,084,589 shares of the company’s stock, valued at $14,284,037.13. This represents a 8.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Calumet Specialty Products Partners Stock Up 1.7%

CLMT stock opened at $13.44 on Friday. The firm has a market capitalization of $1.16 billion, a PE ratio of -4.87 and a beta of 0.91. Calumet Specialty Products Partners, L.P. has a twelve month low of $7.68 and a twelve month high of $25.29. The stock has a 50-day simple moving average of $11.75 and a two-hundred day simple moving average of $15.59.

Calumet Specialty Products Partners (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The company had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.51) earnings per share. On average, equities research analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently weighed in on CLMT. UBS Group raised Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and decreased their price objective for the stock from $15.00 to $12.00 in a report on Monday, March 17th. HC Wainwright reiterated a “buy” rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. The Goldman Sachs Group reduced their target price on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday, April 30th. Wells Fargo & Company reduced their price objective on shares of Calumet Specialty Products Partners from $23.00 to $21.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Finally, Bank of America began coverage on shares of Calumet Specialty Products Partners in a research note on Tuesday, May 13th. They issued a “buy” rating and a $15.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $18.50.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.